Kari J Kurppa

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Induced Apoptosis

Top Venues

EMBO molecular medicine

Cancer research communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Majid Momeny, Mari Tienhaara, Mukund Sharma, Deepankar Chakroborty, Roosa Varjus, Iina Takala, Joni Merisaari, Artur Padzik, Andreas Vogt, Ilkka Paatero, Klaus Elenius, Teemu Daniel Laajala, Kari J Kurppa, Jukka Westermarck
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO molecular medicine 16 (7) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Jan Mueller, Roman R Schimmer, Christian Koch, Florin Schneiter, Jonas Fullin, Veronika Lysenko, Christian Pellegrino, Nancy Klemm, Norman Russkamp, Renier Myburgh, Laura Volta, Alexandre Pa Theocharides, Kari J Kurppa, Benjamin L Ebert, Timm Schroeder, Markus Gabriel Manz, Steffen Boettcher
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells. EMBO molecular medicine 16 (3) (2024)
Majid Momeny, Mari Tienhaara, Mukund Sharma, Deepankar Chakroborty, Roosa Varjus, Iina Takala, Joni Merisaari, Artur Padzik, Andreas Vogt, Ilkka Paatero, Klaus Elenius, Teemu Daniel Laajala, Kari J Kurppa, Jukka Westermarck
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO molecular medicine 16 (7) (2024)
Majid Momeny, Mari Tienhaara, Mukund Sharma, Deepankar Chakroborty, Roosa Varjus, Iina Takala, Joni Merisaari, Artur Padzik, Andreas Vogt, Ilkka Paatero, Klaus Elenius, Teemu Daniel Laajala, Kari J Kurppa, Jukka Westermarck
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO molecular medicine 16 (7) (2024)
Majid Momeny, Mari Tienhaara, Mukund Sharma, Deepankar Chakroborty, Roosa Varjus, Iina Takala, Joni Merisaari, Artur Padzik, Andreas Vogt, Ilkka Paatero, Klaus Elenius, Teemu Daniel Laajala, Kari J Kurppa, Jukka Westermarck
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO molecular medicine 16 (7) (2024)
Majid Momeny, Mari Tienhaara, Mukund Sharma, Deepankar Chakroborty, Roosa Varjus, Iina Takala, Joni Merisaari, Artur Padzik, Andreas Vogt, Ilkka Paatero, Klaus Elenius, Teemu Daniel Laajala, Kari J Kurppa, Jukka Westermarck
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer. EMBO molecular medicine (2024)
Deepankar Chakroborty, Veera K Ojala, Anna M Knittle, Jasmin Drexler, Mahlet Z Tamirat, Regina Ruzicka, Karin Bosch, Johanna Woertl, Susanne Schmittner, Laura L Elo, Mark S Johnson, Kari J Kurppa, Flavio Solca, Klaus Elenius
An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations. Cancer research communications 2 (1) (2022)
Roman R Schimmer, Larisa V Kovtonyuk, Nancy Klemm, Jonas Fullin, Sebastian M Stolz, Jan Mueller, Francisco Caiado, Kari J Kurppa, Benjamin L Ebert, Markus G Manz, Steffen Boettcher
TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms. Blood advances 6 (11) (2022)
Deepankar Chakroborty, Veera K Ojala, Anna M Knittle, Jasmin Drexler, Mahlet Z Tamirat, Regina Ruzicka, Karin Bosch, Johanna Woertl, Susanne Schmittner, Laura L Elo, Mark S Johnson, Kari J Kurppa, Flavio Solca, Klaus Elenius
An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations. Cancer research communications 2 (1) (2022)
Yoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, Navin R Mahadevan, Joao V Alessi, Yin Pun Hung, Arrien A Bertram, David E Heppner, Maurício Fernando Silva Almeida Ribeiro, Karina P Sacardo, Rodrigo Saddi, Mariana Petaccia de Macedo, Rafael B Blasco, Jiaqi Li, Kari J Kurppa, Tom Nguyen, Emma Voligny, Guruprasad Ananda, Roberto Chiarle, Artur Katz, Michael Y Tolstorukov, Lynette M Sholl, Pasi A Janne
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors. Nature communications 13 (1) (2022)